UK markets open in 4 hours 17 minutes

Santen Pharmaceutical Co., Ltd. (SZD.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
9.10+0.05 (+0.55%)
At close: 08:03AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in JPY. All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
301,965,000
-
279,037,000
266,257,000
249,605,000
241,555,000
Cost of revenue
123,256,000
-
112,950,000
109,671,000
98,221,000
94,831,000
Gross profit
178,709,000
-
166,087,000
156,586,000
151,384,000
146,724,000
Operating expenses
Research development
25,416,000
-
28,297,000
26,377,000
24,112,000
23,341,000
Selling general and administrative
91,529,000
-
96,257,000
84,499,000
79,554,000
73,360,000
Total operating expenses
140,169,000
-
169,177,000
120,700,000
139,198,000
113,189,000
Operating income or loss
38,540,000
-
-3,090,000
35,886,000
12,186,000
33,535,000
Interest expense
2,664,000
-
1,499,000
1,209,000
1,488,000
2,393,000
Income before tax
29,874,000
-
-5,799,000
35,616,000
11,688,000
32,091,000
Income tax expense
3,171,000
-
9,184,000
8,427,000
2,562,000
10,377,000
Income from continuing operations
26,703,000
-
-14,983,000
27,189,000
9,126,000
21,714,000
Net income
26,642,000
-
-14,948,000
27,218,000
9,311,000
23,618,000
Net income available to common shareholders
26,642,000
-
-14,948,000
27,218,000
9,311,000
23,618,000
Basic EPS
69.51
72.59
-38.60
68.07
23.30
-
Diluted EPS
69.37
72.37
-38.60
67.97
23.26
-
Basic average shares
375,972
367,020
387,420
399,775
399,456
-
Diluted average shares
376,471
368,136
387,420
400,441
400,387
-